USNA on NYSE

USANA Health Sciences

American direct sales company

USANA Health Sciences, Inc., or USANA, is an American direct sales company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 19, 2026.

Overview

$925.3MRevenue, fiscal 20265
$10.8MNet income, fiscal 20265
1992Founded1

Compare with Tilray, Trulieve Cannabis Corp. or Curaleaf Holdings, Inc., or pick any stock.

  • TickerUSNA on NYSE1
  • Industryfood industry1
  • HeadquartersSalt Lake City1
  • Founded inWest Valley City1
  • Websitewww.usana.com
  • Incorporated inUT6
  • Business address3838 West Parkway Blvd., Salt Lake City, Ut 84120-63366
  • Filer categoryAccelerated filer6
  • Legal formProfit Corporation4
  • LEI549300YTURXE814MAH964
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O CORPORATION SERVICE COMPANY, 84101 Salt Lake City, United States4
  • Registered withUtah Division of Corporations & Commercial Code (Department of Commerce), 1175041-01424
Green-Marque
Photo: USANA Health Sciences, CC BY-SA 3.0, via Wikimedia Commons8

USANA Health Sciences, Inc., or USANA, is an American direct sales company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

78.3%Gross margin5
4.0%Operating margin5
1.2%Net margin5
2.0%Return on equity5
$8.5MFree cash flow5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Core Nutritional brought in 84% of the revenue USANA Health Sciences broke down this way in fiscal 2025.

  1. Core Nutritional$775.5M584%down 8% from 2024
  2. Hiya$132.0M514%up 6599% from 2024
  3. All Other$17.8M52%up 164% from 2024
Business segments by year
Business segments202320242025
Core Nutritional$915.2M$845.8M$775.5M
Hiya$2.0M$132.0M
All Other$5.8M$6.7M$17.8M

Regions

Greater China brought in 27% of the revenue USANA Health Sciences broke down this way in fiscal 2025.

  1. Greater China$424.5M527%down 7% from 2024
  2. [Canada]$381.8M524%down 8% from 2024
  3. Americas And Europe$298.1M519%up 74% from 2024
  4. United States$224.9M514%up 145% from 2024
  5. Southeast Asia Pacific$132.0M58%down 10% from 2024
  6. North Asia$70.6M54%down 10% from 2024
  7. South Korea$68.9M54%down 10% from 2024
Regions by year
Regions202320242025
Greater China$475.1M$458.0M$424.5M
[Canada]$427.3M$413.5M$381.8M
Americas And Europe$180.6M$171.5M$298.1M
United States$95.9M$91.8M$224.9M
Southeast Asia Pacific$163.9M$146.8M$132.0M
North Asia$101.4M$78.2M$70.6M
South Korea$99.1M$76.4M$68.9M

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue22¢$200.9M
  • Research and development1¢$10.7M
  • Selling, general and admin36¢$337.4M
  • Other costs36¢$335.5M
  • Income tax3¢$30.1M
  • Profit1¢$10.8M

Out of $925.3M in revenue.5

Where each dollar of operating cash went, fiscal 2026

  • Capital spending33¢$13.8M
  • Share buybacks67¢$27.5M

Out of $22.3M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.5

Financial statements

Revenue910115$925.3M in 2026−13% since 2019
0$500.0M$1.0B$1.5B2019: $1.1B$1.1B20192021: $1.1B$1.1B2021+7%2022: $998.6M$998.6M2022−12%2023: $921.0M$921.0M2023−8%2024: $854.5M$854.5M2024−7%2026: $925.3M$925.3M2026+8%
Gross profit910115$724.4M in 2026−17% since 2019
0$250.0M$500.0M$750.0M$1.0B2019: $873.4M$873.4M20192021: $925.5M$925.5M2021+6%2022: $804.7M$804.7M2022−13%2023: $744.3M$744.3M2023−8%2024: $693.3M$693.3M2024−7%2026: $724.4M$724.4M2026+4%
Operating income910115$37.4M in 2026−74% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $146.2M$146.2M20192021: $176.5M$176.5M2021+21%2022: $107.6M$107.6M2022−39%2023: $93.1M$93.1M2023−14%2024: $66.3M$66.3M2024−29%2026: $37.4M$37.4M2026−44%
Net income910115$10.8M in 2026−89% since 2019
0$50.0M$100.0M$150.0M2019: $100.5M$100.5M20192021: $124.7M$124.7M2021+24%2022: $69.3M$69.3M2022−44%2023: $63.8M$63.8M2023−8%2024: $42.0M$42.0M2024−34%2026: $10.8M$10.8M2026−74%

Every line of the income statement as filed: the last 3 fiscal years, latest first.5

Period ending2025-12-312024-12-312023-12-31
Net sales$925.3M$854.5M$921.0M
Cost of sales$200.9M$161.2M$176.7M
Gross profit$724.4M$693.3M$744.3M
Brand Partner incentives$336.2M$363.7M$394.3M
Selling, general and administrative$337.4M$263.3M$257.0M
Impairment$7.0M$0$0
Cost realignment$6.5M$0$0
Total operating expenses$687.0M$627.0M$651.2M
Earnings from operations$37.4M$66.3M$93.1M
Interest income$2.4M$11.3M$9.6M
Interest expense-$842.0K-$281.0K-$262.0K
Other, net$2.5M-$1.0M$7.0K
Other income (expense), net$4.1M$10.0M$9.4M
Earnings before income taxes$41.5M$76.4M$102.5M
Income taxes$30.1M$34.3M$38.7M
Net earnings$11.5M$42.1M$63.8M
Less: Net earnings attributable to redeemable noncontrolling interest$717.0K$30.0K$0
Net earnings attributable to USANA$10.8M$42.0M$63.8M
Basic (in dollars per share)$0.58$2.20$3.31
Diluted (in dollars per share)$0.58$2.19$3.30
Basic (in shares)18.5M shares19.1M shares19.2M shares
Diluted (in shares)18.6M shares19.2M shares19.3M shares
Foreign currency translation adjustment$7.2M-$9.4M-$1.3M
Tax benefit (expense) related to foreign currency translation adjustment-$658.0K$434.0K$390.0K
Other comprehensive income (loss), net of tax$6.5M-$9.0M-$908.0K
Comprehensive income$18.0M$33.1M$62.9M
Less: comprehensive income attributable to redeemable noncontrolling interest$717.0K$30.0K$0
Comprehensive income attributable to USANA$17.3M$33.1M$62.9M

Compare USANA Health Sciences with another company

The story

Founded by Myron W. Wentz in 1992, in West Valley City.1

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its brand partnersor by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. In 2026, the Kids Eat program continued efforts to address childhood food insecurity in Utah by providing food bags to students and allowing businesses, families, and other organizations to sponsor participating schools. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

The USANA Foundation was founded in 2012 and has provided hundreds of millions of meals in more than 45 countries. Their programs include USANA Kids Eat and the USANA Garden Towers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

Read the full text

In 2024, USANA acquired a 79% stake in children's health and wellness company Hiya Health in a $260 million transaction, making Hiya a subsidiary of USANA. At the time of the acquisition, Hiya had grown to approximately $100 million in annual sales and offered eight children's health products, including multivitamins, probiotics, iron supplements, and immune support products.

From Wikipedia’s article on USANA Health Sciences, shared under CC BY-SA 4.0.7

Leadership

Who has led USANA Health Sciences, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (31)

Products and brands

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

USANA began using InCelligence Technology in August 2016 and registered it as a U.S. trademark in March 2017. The technology is used in the company's CellSentials nutritional supplement system, including its Core Minerals and Vita-Antioxidant products, which USANA markets as using its InCelligence Complex to support cellular protection and renewal. As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

From Wikipedia’s article on USANA Health Sciences, shared under CC BY-SA 4.0.7

Subsidiaries and ownership

Subsidiaries

From Wikidata.1

Former names

  • USANA INCJul 23, 1996 to Apr 27, 20006

Timeline

  1. Feb 7, 2023New chief executive Kevin Guest becomes CEO16
  2. Feb 14, 2007New chief executive Myron W. Wentz becomes CEO17
  3. May 30, 1996Went public Listed on NYSE1
  4. 1992Founded Founded in West Valley City1

Filings

579 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 40 major events, 424 insider forms, 20 large holders, 75 other. The latest 20:

  1. Oct 5, 20268-K EDGAR
  2. Aug 13, 2026SCHEDULE 13G/A EDGAR
  3. Aug 13, 202610-Q EDGAR
  4. Aug 4, 20268-K EDGAR
  5. Jul 27, 20264 EDGAR
  6. Jul 27, 20264 EDGAR
  7. Jul 27, 20264 EDGAR
  8. Jul 27, 20264 EDGAR
  9. Jul 27, 20264 EDGAR
  10. Jul 27, 20264 EDGAR
  11. Jul 27, 20264 EDGAR
  12. Jul 27, 20264 EDGAR
  13. Jul 27, 20264 EDGAR
  14. Jun 18, 20264 EDGAR
  15. Jun 16, 2026144 EDGAR
  16. Jun 16, 20264 EDGAR
  17. Jun 15, 2026144 EDGAR
  18. Jun 15, 202611-K EDGAR
  19. Jun 8, 2026144 EDGAR
  20. Jun 8, 20264 EDGAR

The 579 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

110 open-market trades by officers, directors and large owners since October 2021: 0 buys and 110 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 16, 2026Neidig BrentCHIEF COMMERCIAL OFFICERSale5,002$19.45$97.3KForm 4
Jun 15, 2026Neidig BrentCHIEF COMMERCIAL OFFICERSale909$20.01$18.2KForm 4
Jun 12, 2026Neidig BrentCHIEF COMMERCIAL OFFICERSale1,602$20.15$32.3KForm 4
Jun 8, 2026Jones Paul A.CHIEF PEOPLE OFFICERSale5,561$18.50$102.9KForm 4
Jun 1, 2026Fleming John TurmanDirectorSale2,450$17.93$43.9KForm 4
May 28, 2026Jones Paul A.CHIEF PEOPLE OFFICERSale6,813$18.95$129.1KForm 4
May 27, 2026IIEKKING G DOUGCHIEF FINANCIAL OFFICERSale5,360$18.75$100.5KForm 4
May 22, 2026FULLER GILBERT ADirectorSale1,057$18.66$19.7KForm 4
May 7, 2026Foukas JoshuaCHIEF LEGAL OFFICERSale3,791$19.82$75.1KForm 4
Mar 20, 2026FULLER GILBERT ADirectorSale1,058$17.00$18.0KForm 4
Mar 3, 2026Benedict PeterCHIEF INFORMATION OFFICERSale4,553$19.38$88.2KForm 4
Feb 20, 2026Foukas JoshuaCHIEF LEGAL OFFICERSale4,461$21.35$95.2KForm 4
Dec 10, 2025Benedict PeterCHIEF INFORMATION OFFICERSale2,673$20.95$56.0KForm 4
Dec 10, 2025Mulham David MulhamCHIEF SALES OFFICERSale873$21.00$18.3KForm 4
Nov 10, 2025Winssinger Frederic JDirectorSale2,000$19.21$38.4KForm 4
Nov 3, 2025FULLER GILBERT ADirectorSale1,057$21.48$22.7KForm 4
Oct 31, 2025Fleming John TurmanDirectorSale1,750$19.79$34.6KForm 4
Aug 7, 2025FULLER GILBERT ADirectorSale1,058$29.10$30.8KForm 4
Jul 30, 2025Mulham David MulhamCHIEF SALES OFFICERSale3,515$30.26$106.4KForm 4
Jun 9, 2025Fleming John TurmanDirectorSale500$29.66$14.8KForm 4

All 110 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Nantahala Capital Management, LLC1,620,148$34.6M1.1%+810,074
BlackRock, Inc.1,554,189$33.2M0.0%+363,773
Pzena Investment Management LLC1,205,587$25.7M0.1%+96,654
Renaissance Technologies LLC958,520$20.5M0.0%−59,110
Dimensional Fund Advisors LP837,426$17.9M0.0%+3,203
Vanguard Capital Management LLC487,370$10.4M0.0%+8,327
Creative Planning417,971$8.9M0.0%+224,823
Aqr Capital Management LLC408,086$8.7M0.0%+111,666
Vanguard Portfolio Management LLC363,377$7.8M0.0%+25,103
Geode Capital Management, LLC283,165$6.0M0.0%+18,731
Charles Schwab Investment Management Inc272,208$5.8M0.0%−60,904
State Street Corp261,240$5.6M0.0%+13,205
Nuveen, LLC239,477$5.1M0.0%+216,998
American Century Companies Inc187,348$4.0M0.0%−3,604
Jacobs Levy Equity Management, Inc180,567$3.9M0.0%−12,409
Two Sigma Investments, LP165,514$3.5M0.0%+20,884
Morgan Stanley164,363$3.5M0.0%+8,879
D. E. Shaw & Co., Inc.156,835$3.3M0.0%−25,648
Allianz Asset Management GmbH142,399$3.0M0.0%+24,900
Bridgeway Capital Management, LLC138,153$2.9M0.1%+39,060
Algert Global LLC131,758$2.8M0.0%+63,074
Goldman Sachs Group Inc123,267$2.6M0.0%+32,118
UBS Group AG115,886$2.5M0.0%+92,174
Lazard Asset Management LLC97,311$2.1M0.0%+24,916
Northern Trust Corp94,467$2.0M0.0%−3,900

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63